论文部分内容阅读
1983年,人心房钠利尿激素(人心钠肽、hANP)的构造被阐明。存在于血中的α型 ANP 具有很强的排水、利尿、扩血管和降压作用。充血性心力衰竭、高血压及肾功能不全时,ANP 分泌增加。此外,将αhANP静脉用药,也正试用于临床。心律不齐、阵发性室上性心动过速(PSVT)、心房纤颤、心房扑动时,ANP 分泌亦增加,并成为 PSVT时多尿的主要机理。此外,研究 PSVT 时对 ANP 的分泌动态及调节机理的临床模型也是重要的。一、心律不齐时 ANP 分泌动态及其他体液性因素的变化1.PST 时 ANP 的分泌功态作者的自验例为无原发性心脏疾病,36岁女性,
In 1983, the structure of human atrial natriuretic (human atrial natriuretic peptide, hANP) was elucidated. Alpha-type ANP present in the blood has strong drainage, diuresis, vasodilation and antihypertensive effects. Congestive heart failure, hypertension and renal insufficiency, ANP secretion increased. In addition, αhANP intravenous drug, is also being tested in clinical. Arrhythmia, paroxysmal supraventricular tachycardia (PSVT), atrial fibrillation, atrial flutter, ANP secretion also increased, and become the main mechanism of polyuria PSVT. In addition, the study of the dynamics of ANP secretion during PSVT and the clinical model of regulatory mechanisms are also important. First, the arrhythmia ANP secretion dynamics and other changes in body fluid factors 1.PST when the secretion of ANP The author’s self-examination of non-primary heart disease, 36-year-old female,